As of 2026-09-16, the Relative Valuation of Revolution Medicines Inc (RVMD) is (115.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 204.86 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -156.2%.
The range of the Relative Valuation is (100.60) - (128.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.2x - 29.7x | 26.4x |
| Forward P/E multiples | 23.3x - 30.4x | 26.8x |
| Fair Price | (100.60) - (128.23) | (115.06) |
| Upside | -149.1% - -162.6% | -156.2% |
| Date | P/E |
| 2026-09-15 | -47.45 |
| 2026-09-14 | -47.51 |
| 2026-09-11 | -47.20 |
| 2026-09-10 | -47.10 |
| 2026-09-09 | -48.10 |
| 2026-09-08 | -48.02 |
| 2026-09-04 | -48.64 |
| 2026-09-03 | -48.84 |
| 2026-09-02 | -48.46 |
| 2026-09-01 | -48.61 |
| 2026-08-31 | -47.61 |
| 2026-08-28 | -48.15 |
| 2026-08-27 | -51.22 |
| 2026-08-26 | -49.90 |
| 2026-08-25 | -48.96 |
| 2026-08-24 | -49.01 |
| 2026-08-21 | -48.52 |
| 2026-08-20 | -49.04 |
| 2026-08-19 | -49.72 |
| 2026-08-18 | -50.03 |
| 2026-08-17 | -49.10 |
| 2026-08-14 | -47.18 |
| 2026-08-13 | -46.79 |
| 2026-08-12 | -47.54 |
| 2026-08-11 | -47.61 |
| 2026-08-10 | -47.94 |
| 2026-08-07 | -47.52 |
| 2026-08-06 | -45.82 |
| 2026-08-05 | -45.70 |
| 2026-08-04 | -44.81 |
| 2026-08-03 | -42.26 |
| 2026-07-31 | -43.44 |
| 2026-07-30 | -44.51 |
| 2026-07-29 | -41.90 |
| 2026-07-28 | -42.59 |
| 2026-07-27 | -43.56 |
| 2026-07-24 | -43.83 |
| 2026-07-23 | -43.72 |
| 2026-07-22 | -42.39 |
| 2026-07-21 | -42.45 |
| 2026-07-20 | -41.78 |
| 2026-07-17 | -43.12 |
| 2026-07-16 | -41.50 |
| 2026-07-15 | -42.72 |
| 2026-07-14 | -42.84 |
| 2026-07-13 | -42.61 |
| 2026-07-10 | -43.29 |
| 2026-07-09 | -44.27 |
| 2026-07-08 | -43.95 |
| 2026-07-07 | -44.11 |